Aditya Birla Sun Life Pharma and Healthcare Fund is a Thematic fund run by Aditya Birla Sun Life Mutual Fund. On 30-09-2026, it managed ₹1,078 Cr of investors' money. In the 3 years to 30-10-2026, its Direct plan returned 21.1% a year and its Regular plan returned 19.5% a year. Its benchmark, BSE Healthcare TRI, returned 23.0% a year over the same 3 years.
NAV (Direct plan)
₹39.28
▲ 0.59% · 30-10-2026
NAV (Regular plan)
₹35.18
▲ 0.60% · 30-10-2026
Expense ratio
1.08%Direct2.31%Regular
1.08%
A year
Riskometer
Very High
Set by the fund house
3 year return
21.1%Direct19.5%Regular
21.1%
A year
Aditya Birla Sun Life Pharma and Healthcare Fund NAV Today
NAV on 30-10-2026: Direct Plan Growth ₹39.28 (up 0.59% that day); Regular Plan Growth ₹35.18 (up 0.60% that day).
This fund (Direct plan)
₹39.28
Aditya Birla Sun Life Pharma and Healthcare Fund Returns vs BSE Healthcare TRI
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
Trailing returns
Period
1M
3M
6M
1Y
3Y
5Y
10Y
This fund (Direct)
−1.11%
−2.63%
+12.00%
+14.15%
+21.08%
+14.76%
--
This fund (Regular)
−1.24%
−2.92%
+11.29%
+12.65%
+19.47%
+13.18%
--
BSE Healthcare TRI
+0.24%
−0.99%
+12.80%
+12.37%
+23.01%
+15.61%
+12.48%
Thematic average
−2.09%
−4.52%
+0.86%
−1.22%
+13.76%
+11.62%
--
Best in Thematic
+11.54%
+11.27%
+22.16%
+75.71%
+54.78%
+21.14%
--
Worst in Thematic
−16.05%
−11.74%
−13.97%
−22.44%
−4.46%
+3.65%
--
Rank in Thematic
66/235
55/232
23/232
15/215
16/133
26/96
--
Category rows compare the Direct plans of 235 Thematic funds. Rank 1 is the highest return.
Aditya Birla Sun Life Pharma and Healthcare Fund Year-wise Returns
Return of each calendar year
Year
Direct
Regular
BSE Healthcare TRI
2026to date
+15.94%
+14.67%
+15.08%
2025
−3.09%
−4.30%
−2.72%
2024
+37.69%
+35.79%
+44.30%
2023
+39.58%
+37.67%
+37.97%
2022
−11.31%
−12.68%
−11.50%
2021
+21.36%
+19.54%
+21.54%
Aditya Birla Sun Life Pharma and Healthcare Fund Rolling Returns
The return of every holding period in the fund's history, not only the one that ends today
Rolling returns
Each point is the yearly return of one 3-year holding period, plotted on the day it ended. There are 1,060 periods, one for each trading day from 11-07-2022 to 30-10-2026.
0%5%10%15%20%25%30%
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
BSE Healthcare TRI
Nov 2019 to Nov 2022Aug 2020 to Aug 2023May 2021 to May 2024Jan 2022 to Jan 2025Oct 2022 to Oct 2025Jun 2023 to Jun 2026
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)BSE Healthcare TRI
0%
0%
Below 0%
0%
0%
0-5%
0%
0%
5-10%
16%
15%
10-15%
35%
28%
15-20%
44%
41%
20-25%
6%
15%
Above 25%
Every holding period at a glance
Period
Periods
Median
Lowest
Highest
With a loss
Benchmark median
Beat benchmark
1 year
1,556
18.0%
−15.5%
72.9%
20%
19.3%
47%
2 years
1,307
19.8%
−2.3%
45.0%
2%
20.5%
33%
3 years
1,060
19.9%
12.1%
27.8%
0%
21.0%
23%
5 years
569
18.1%
12.9%
29.3%
0%
19.2%
8%
7 years
76
21.7%
20.1%
22.3%
0%
22.6%
0%
Every SIP holding period at a glance
Period
Periods
Median
Lowest
Highest
With a loss
Benchmark median
Beat benchmark
1 year
76
23.5%
−20.2%
70.0%
20%
22.1%
46%
2 years
64
16.8%
−7.0%
51.1%
11%
16.9%
41%
3 years
52
18.4%
2.2%
36.4%
0%
18.9%
33%
5 years
28
19.1%
14.2%
28.4%
0%
20.6%
4%
Lumpsum: the yearly rate (CAGR) from the NAV on a period's first day to the NAV on its last. SIP: the XIRR of the monthly instalments and their value on the last day. "With a loss" counts the periods that ended below the money put in. "Beat benchmark" counts the periods in which the fund did better than BSE Healthcare TRI over the same days. Past returns do not promise future returns.
Aditya Birla Sun Life Pharma and Healthcare Fund Risk
How much it swings, and the falls an investor had to sit through
Risk and return
Measure
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)This fund
BSE Healthcare TRI
Return (CAGR)
+14.15%
+12.37%
Standard deviation
12.28%
13.56%
Sharpe ratio
0.73
0.53
Sortino ratio
1.07
0.77
Maximum drawdown
−9.6%
(23-10-2026)
−9.9%
(23-10-2026)
Beta
0.87
1.00
Alpha
+2.70%
0.00%
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.
Measure
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)This fund
BSE Healthcare TRI
Return (CAGR)
+21.08%
+23.01%
Standard deviation
12.82%
14.12%
Sharpe ratio
1.17
1.20
Sortino ratio
1.69
1.71
Maximum drawdown
−15.9%
(28-02-2025)
−16.2%
(28-02-2025)
Beta
0.87
1.00
Alpha
+0.27%
0.00%
From daily NAVs, 30-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.
Measure
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)This fund
BSE Healthcare TRI
Return (CAGR)
+14.76%
+15.61%
Standard deviation
12.83%
13.97%
Sharpe ratio
0.70
0.70
Sortino ratio
1.00
1.00
Maximum drawdown
−18.7%
(17-06-2022)
−19.6%
(17-06-2022)
Beta
0.88
1.00
Alpha
+0.29%
0.00%
From daily NAVs, 29-10-2021 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.
Measure
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)This fund
BSE Healthcare TRI
Return (CAGR)
+20.52%
+21.30%
Standard deviation
14.89%
16.49%
Sharpe ratio
1.03
0.98
Sortino ratio
1.51
1.41
Maximum drawdown
−20.5%
(17-06-2022)
−24.1%
(23-03-2020)
Beta
0.88
1.00
Alpha
+1.23%
0.00%
From daily NAVs, 11-07-2019 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
−25%−20%−15%−10%−5%0%
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
BSE Healthcare TRI
2020202120222023202420252026
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)BSE Healthcare TRI
Worst fall
High before it
Bottom
Back at the high
Time to climb back
Below its high today
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
−20.5%
16-09-2021
17-06-2022
20-07-2023
13 months
−4.7%
BSE Healthcare TRI
−24.1%
20-02-2020
23-03-2020
09-04-2020
17 days
−3.8%
From the Direct plan's daily NAV since 11-07-2019, adjusted for unit splits, and BSE Healthcare TRI over the same days. "Time to climb back" runs from the bottom to the first day back at the old high.
Aditya Birla Sun Life Pharma and Healthcare Fund vs Other Thematic Funds
The five Thematic funds with the best three year return, and this fund. Direct plans.
AUM is each fund's size at the end of its last reported month, from its own portfolio file. We calculate the risk ratios from daily NAVs over the last three years. The risk-free return is what NSE's overnight rate index earned over the same years. Alpha and beta compare each fund with its own benchmark's TRI. "--" means we have no figure: for alpha and beta, no daily series for that benchmark.
Aditya Birla Sun Life Pharma and Healthcare Fund Expense Ratio and Costs
What each plan charges a year, in force from 19-10-2026
Plan
Base expense ratio
Brokerage
Transaction costs
Levies and GST
Total expense ratio
Thematic median
Cost rank (1 = cheapest)
Direct
0.84%
0.03%
0.00%
0.21%
1.08%
1.18%
87/235
Regular
1.91%
0.03%
0.00%
0.37%
2.31%
2.41%
95/235
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, the cost of executing trades, and statutory levies with GST. From AMFI's expense ratio file. Cost rank: where this plan comes when the Thematic funds' plans of the same type are sorted from the lowest total expense ratio to the highest.
Direct vs Regular: what the gap cost
Both plans own the same portfolio, so the difference in what they earned is the Regular plan's extra cost, taken out of its NAV.
Over the last
Regular
Direct
Direct earned more by
₹1 lakh became (Regular)
₹1 lakh became (Direct)
1 year
12.65%
14.15%
1.50%
₹1,12,650
₹1,14,150
3 years
19.47%
21.08%
1.61% a year
₹1,70,520
₹1,77,508
5 years
13.18%
14.76%
1.58% a year
₹1,85,716
₹1,99,046
Returns over more than 1 year are a rate a year (CAGR). ₹1 lakh invested once at the start of each period, valued on the last NAV.
Aditya Birla Sun Life Pharma and Healthcare Fund SIP Calculator
What a one-time or monthly investment in this fund would be worth today, from its own NAV history
Growth of an investment
Step up each year
PeriodFor
₹10,000 on the first trading day of every month, from 11-07-2019 to 30-10-2026: 88 instalments, ₹8,80,000 in all.
Investment
Invested
Value now
Gain
Return a year
Direct planAditya Birla Sun Life Pharma and Healthcare Fund (Direct)
₹8,80,000
₹17,52,233
₹8,72,233
18.4%
Regular planAditya Birla Sun Life Pharma and Healthcare Fund (Regular)
Direct planAditya Birla Sun Life Pharma and Healthcare Fund (Direct)Regular planAditya Birla Sun Life Pharma and Healthcare Fund (Regular)BSE Healthcare TRICategory averageCategory average, 235 Thematic fundsAmount invested
From each plan's published NAV (Growth option), the benchmark's TRI and the category average, over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Aditya Birla Sun Life Pharma and Healthcare Fund Asset Allocation
Asset allocation as on 30-09-2026
What the fund holds
97.9%Equity
Asset
Fund
Category
Equity
97.9%
94.5%
Cash and others
2.1%
4.0%
Market cap of stocks
Market cap
Fund
Category
Large Cap
32.9%
45.7%
Mid Cap
30.6%
19.6%
Small Cap
31.7%
24.1%
Not on AMFI's list
2.6%
2.3%
Share of the whole fund. Category: the average of the Thematic funds that hold stocks. Groups follow AMFI's latest list, as SEBI defines them: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Aditya Birla Sun Life Pharma and Healthcare Fund Sector Allocation
Sector allocation of the fund's stocks as on 30-09-2026
Largest sectors
Pharmaceuticals & Biotechnology74.9%
Healthcare Services21.6%
Insurance0.7%
Chemicals & Petrochemicals0.7%
Sector changes
Sector
July 2026
August 2026
September 2026
Change
Pharmaceuticals & Biotechnology
74.2%
73.3%
74.9%
+0.7%
Healthcare Services
21.8%
21.6%
21.6%
−0.2%
Insurance
0.9%
0.8%
0.7%
−0.2%
Chemicals & Petrochemicals
0.8%
0.8%
0.7%
−0.1%
Each sector's share of the fund at the end of each month. The five largest sectors of September 2026. Change: from July 2026 to September 2026, in % of the fund.
Aditya Birla Sun Life Pharma and Healthcare Fund Portfolio Holdings
As on 30-09-2026 · 39 holdings · from the fund house's monthly portfolio
Holdings
Sector
Weight%
Holdings trend
1M change
Torrent Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
9.28%
0.0%
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
8.61%
0.0%
Apollo Hospitals Enterprise Ltd.
Healthcare Services
6.44%
0.0%
Cipla Ltd.
Pharmaceuticals & Biotechnology
6.38%
+26.3%
Aurobindo Pharma Ltd.
Pharmaceuticals & Biotechnology
4.52%
0.0%
Sai Life Sciences Ltd.
Pharmaceuticals & Biotechnology
4.49%
0.0%
Ajanta Pharma Ltd.
Pharmaceuticals & Biotechnology
4.35%
0.0%
Mankind Pharma Ltd.
Pharmaceuticals & Biotechnology
3.62%
0.0%
Dr. Lal Path labs Ltd.
Healthcare Services
3.51%
+58.7%
Abbott India Ltd.
Pharmaceuticals & Biotechnology
3.26%
0.0%
Emcure Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
3.21%
0.0%
Lupin Ltd.
Pharmaceuticals & Biotechnology
2.94%
0.0%
IPCA Laboratories Ltd.
Pharmaceuticals & Biotechnology
2.71%
0.0%
Gland Pharma Ltd.
Pharmaceuticals & Biotechnology
2.70%
0.0%
Fortis Healthcare Ltd.
Healthcare Services
2.42%
0.0%
Corona Remedies Ltd.
Pharmaceuticals & Biotechnology
2.27%
0.0%
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
2.24%
0.0%
Procter & Gamble Health Ltd.
Pharmaceuticals & Biotechnology
1.82%
0.0%
Thyrocare Technologies Ltd.
Healthcare Services
1.76%
0.0%
Alkem Laboratories Ltd.
Pharmaceuticals & Biotechnology
1.68%
0.0%
Jupiter Life Line Hospitals Ltd.
Healthcare Services
1.55%
0.0%
Metropolis Healthcare Ltd.
Healthcare Services
1.48%
0.0%
Biocon Ltd.
Pharmaceuticals & Biotechnology
1.45%
+33.1%
Shilpa Medicare Ltd.
Pharmaceuticals & Biotechnology
1.43%
0.0%
Piramal Pharma Ltd.
Pharmaceuticals & Biotechnology
1.22%
0.0%
Dr. Reddy's Laboratories Ltd.
Pharmaceuticals & Biotechnology
1.13%
0.0%
Anthem Biosciences Ltd.
Pharmaceuticals & Biotechnology
1.13%
0.0%
Sanofi Consumer Healthcare India Ltd.
Pharmaceuticals & Biotechnology
1.11%
0.0%
Suraksha Diagnostic Ltd.
Healthcare Services
1.10%
0.0%
Manipal Health Enterprises Ltd
Healthcare Services
1.07%
0.0%
Vijaya Diagnostic Centre Ltd.
Healthcare Services
1.04%
0.0%
Pfizer Ltd.
Pharmaceuticals & Biotechnology
1.01%
0.0%
Natco Pharma Ltd.
Pharmaceuticals & Biotechnology
0.92%
0.0%
Glaxosmithkline Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
0.83%
0.0%
Medi Assist Healthcare Services Ltd.
Insurance
0.73%
0.0%
Vinati Organics Ltd.
Chemicals & Petrochemicals
0.69%
0.0%
Syngene International Ltd.
Healthcare Services
0.64%
0.0%
Max Healthcare Institute Ltd.
Healthcare Services
0.60%
0.0%
Jubilant Pharmova Ltd.
Pharmaceuticals & Biotechnology
0.60%
0.0%
Aditya Birla Sun Life Pharma and Healthcare Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
Stocks bought and sold in September 2026
Cipla Ltd.
↑Added
+26.3%
6.38%
Dr. Lal Path labs Ltd.
↑Added
+58.7%
3.51%
Biocon Ltd.
↑Added
+33.1%
1.45%
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Overlap: for each holding both funds own, the smaller of its two weights, added up. 40% means 40% of each fund's money sits in positions the other also holds. From each fund's latest monthly portfolio, matched by ISIN. Cash and hedged positions are left out. Funds that overlap under 10% are not listed. A high overlap does not make two funds the same: their costs, lock-in and category can differ.
Aditya Birla Sun Life Pharma and Healthcare Fund Overview
Fund facts from the scheme summary document, as on 16-10-2026
Expense ratio (Direct)
1.08%
Expense ratio (Regular)
2.31%
Category
Thematic
Risk
Very High
Benchmark
BSE Healthcare TRI
Launch date
11-07-2019
Minimum investment
₹1,000
Minimum additional investment
₹1,000
AUM
₹1,077.52 Cr (30-09-2026)
Lock in
None
Scheme code (Direct)
147409
ISIN (Direct)
INF209KB1O25
Scheme code (Regular)
147407
ISIN (Regular)
INF209KB1N91
NAV history
From 11-07-2019, 7.3 years
Exit load
Exit load of 1% if redeemed within 30 days.
Tax on Aditya Birla Sun Life Pharma and Healthcare Fund returns
Aditya Birla Sun Life Pharma and Healthcare Fund is taxed as an equity fund: 65% or more of it is in Indian stocks.
Units sold within 1 year: the gain is taxed at 20%.
Units held longer: gains above ₹1.25 lakh in a financial year, across all your equity funds and shares, are taxed at 12.5%.
IDCW (dividend) payouts are added to your income and taxed at your slab rate.
A stamp duty of 0.005% is deducted when you invest.
Rules in force from 23-07-2024 (Finance Act 2024). Tax depends on your own income; this is general information, not tax advice.
All plans and options
Plan
Option
NAV
As on
direct
Growth
₹39.28
30-10-2026
direct
IDCW
₹25.54
30-10-2026
regular
Growth
₹35.18
30-10-2026
regular
IDCW
₹23.23
30-10-2026
About Aditya Birla Sun Life Pharma and Healthcare Fund
Aditya Birla Sun Life Pharma and Healthcare Fund is a mutual fund from Aditya Birla Sun Life Mutual Fund. Its category is Thematic. It was launched on 11-07-2019. Its benchmark is BSE Healthcare TRI. At the end of September 2026 it held 39 securities.
Fund Manager
Dhaval Shah
Fund manager of Aditya Birla Sun Life Pharma and Healthcare Fund, since 11-07-2019
Frequently Asked Questions for Aditya Birla Sun Life Pharma and Healthcare Fund
What is the current NAV of Aditya Birla Sun Life Pharma and Healthcare Fund?
The Direct plan NAV is ₹39.28. The Regular plan NAV is ₹35.18, as on 30-10-2026.
What are the returns of Aditya Birla Sun Life Pharma and Healthcare Fund?
The Direct plan returned +14.15% in 1 year, +21.08% a year over 3 years, +14.76% a year over 5 years. The Regular plan returned +12.65% in 1 year, +19.47% a year over 3 years, +13.18% a year over 5 years. These figures are as on 30-10-2026.
What is the expense ratio of Aditya Birla Sun Life Pharma and Healthcare Fund?
The Direct plan charges 1.08% a year. The Regular plan charges 2.31% a year. This is the figure the fund house reported to AMFI, in force from 19-10-2026.
What is the AUM of Aditya Birla Sun Life Pharma and Healthcare Fund?
Aditya Birla Sun Life Pharma and Healthcare Fund managed ₹1,077.52 Cr on 30-09-2026, as its fund house reported in its monthly portfolio.
What are the top holdings of Aditya Birla Sun Life Pharma and Healthcare Fund?
At the end of September 2026 the largest holdings were TORNTPHARM (9.28%), SUNPHARMA (8.61%), APOLLOHOSP (6.44%), CIPLA (6.38%), AUROPHARMA (4.52%). The fund held 39 securities in all.
What did Aditya Birla Sun Life Pharma and Healthcare Fund buy and sell in September 2026?
It added shares in 3.
How do I invest in Aditya Birla Sun Life Pharma and Healthcare Fund?
Through Aditya Birla Sun Life Mutual Fund's website or app, a mutual fund distributor, or an investment platform. Choose the Direct plan to pay no distributor commission, or the Regular plan to invest through a distributor. The first investment is at least ₹1,000. You can invest once or through a monthly SIP.
Who is the fund manager of Aditya Birla Sun Life Pharma and Healthcare Fund?
Dhaval Shah (since 11-07-2019).
Sources: NAV and expense ratio from AMFI. Holdings from the fund house's monthly portfolio statement. Fund facts from its scheme summary document, as on 16-10-2026.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.
Track Aditya Birla Sun Life Pharma and Healthcare Fund in WealthGamma
Add this fund once. WealthGamma updates its value every day and shows it next to your stocks, gold, deposits and loans.